It has recently been proposed that plasma concentrations of the soluble part of PD-L1 (sPD-L1) could be a useful biomarker for the characterization of aggressiveness and metastasis in cutaneous melanoma [33,34]. Here, SPDL1 is linked to cutaneous melanoma.